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Abstract 
The cellular factors regulating the generation of/?A4 from the amyloid precursor protein (APP) are unknown. Protein phosphorylation by protein 
kinase C (PKC) has been found to influence the processing and metabolism of APP. In this report, we show that in the human neuroblastoma cell 
line SYSY, PA4 generation from full-length APP is not changed by PKC activation whereas production of the non-amyloidogenic secretory fragment 
(APPsec) and of the C-terminal fragment of/?A4 (~3) are stimulated. In addition,/IA4 generation from the membrane inserted C-terminal 100 residues 
(SPA4CT) of APP is stimulated by PKC activation. Accordingly attempts to divert APP processing from the amyloidogenic,BA4-generating, to the 
non-amyloidogenic, secretory, pathway, have to address the nature and regulation of the two pathways and/or of the process leading to the cleavage 
of APP at the C-terminus of the /?A4 domain. The data reported here suggest that these mechanisms are cell-type specific. 
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1. Introduction 
The /3-amyloid protein (BA4) is a cleavage product of 
the amyloid precursor protein (APP) and accumulates at 
high levels in the brains of Alzheimer’s disease (AD) 
patients. While a large proportion of normal secretory 
processing of APP involves cleavage within the ,L?-amy- 
loid domain and thus precludes /?A4 generation [1,2,3], 
recent reports have shown that P-amyloid related pep- 
tides are also normally secreted by cultured cells and can 
be detected in human cerebrospinal fluid [4,5,6,7]. In 
addition to the it-kDa /?-amyloid peptide (BA4) a 3-kDa 
peptide (~3) corresponding to a truncated fragment of 
/3A4 at residue 16 by APP secretase is also produced [8]. 
It has been reported that activation of PKC in some 
non-neuronal cell culture systems increased the genera- 
tion of secreted forms of APP (APPsec) and p3 but mark- 
edly decrease PA4 release from these cell lines [9,10]. 
To analyse further the regulatory mechanisms in- 
volved in j?A4 generation, especially the relationship be- 
tween the two protease activities generating the N- and 
C-terminus of /?A4 (termed protease 1 = B-secretase and 
protease 2 = y-secretase, respectively) and the /?A4 
cleaving activity (termed APP secretase; ol-secretase), we 
have expressed, in addition to full-length APP695, also 
the C-terminal 100 residues of APP, fused to the APP 
signal sequence (termed SPA4CT), in the human neurob- 
lastoma cell line SY 5Y. Since /?A4 release from SPA4CT- 
type APP fragments which carry the j3A4 sequence at the 
N-terminus, depends only on the protease activity gener- 
ating the C-terminus of/IA4 (i.e. protease 2, y-secretase), 
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and was shown not to be influenced by APP-secretase 
[ Ill, we were able to analyse @A4 generation independent 
of the processes generating the N-terminus of /?A4 or of 
APP secretion. 
2. Experimental procedures 
2. I. Cloning procedures 
Preparation of plasmid DNA, restriction enzyme digestion, agarose 
gel electrophoresis of DNA, DNA ligation and bacterial transforma- 
tion were carried out as described by Sambrook et al. [12]. 
2.2. Plasmid construction 
For construction of CEP/SPA4CT the SmuIIHindlI1 fragment from 
SP65/SPA4CT [I 11 was cloned into pCEP4, digested with PvuIIl 
HindIll. The resulting plasmid CEP/SPA4CT encodes the APP signal 
sequence and two additional residues from APP695 in frame with the 
amyloid /IA4 sequence and the entire C-terminal domain of the APP. 
CEP/APP695 was obtained by cloning the SmaIlHindIII fragment into 
pCEP, digested with PvuII/HindlII. 
2.3. Tissue culture and transfection 
The subclone neuroblastoma cell line SH-SYSY was grown in equal 
parts of Minimum Essential Medium (MEM, with Earle’s Salts and 
L-glutamine) and Ham’s F-12 supplemented with non-essential amino 
acids (Eagle’s formulation), penicillin (50 U/ml), streptomycin (40 pg/ 
ml) and 10% (v/v) fetal calf serum (FCS) (all Gibco/BRL). For stable 
transfection 5 x IO5 cells were seeded onto 60-mm plates, and incubated 
overnight at 37’C. After reaching ca. 80% confluence, cells were 
washed three times with Opti-MEM I (Gibco) prior to addition of 
DNA/Lipofectin mixture. The DNA/Lipofectin mixture was produced 
by combining the DNA solution (lo-2Opg DNA in 1.5 ml Opti-MEM) 
with the Lipofectin solution (30-50 pg Lipofectin (BRL, Eggenstein, 
Germany) in 1.5 ml Opti-MEM). After incubation for 8 h at 37°C cells 
were grown for a further 2448 h in cell-culture medium and stable lines 
were selected by exposure to hygromycin B (300 ,@ml). 
2.4. Pulse-chase labelling of tissue culture cells 
After removal of the culture medium, the cells were treated with 1.5 
ml of MEM lacking methionine for 40 min. Then 500 @Zi of 
[“Slmethionine were added, and cells were labelled for 60 min at 37°C. 
Cells were then washed once with MEM (37°C) and chased in methion- 
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ine-enriched medium (MEM; 0.3 mg/ml L-methionine, 37°C) for the 
times indicated in results. After the chase period, the medium was 
harvested, and the cells were washed once with MEM and scraped from 
the surface of the dish. For lysis, the cells were resuspended in 0.6 ml 
of SOL (50 mM Tris-HCl, pH 7.5, I50 mM NaCl, 2 mM EDTA, 1% 
Triton X-100) supplemented with 2 mM penylmethylsulfonyl fluoride 
(PMSF) and placed on ice. After 20 min, samples were centrifuged at 
10,000 x g for 5 min, and the supernatants (cell lysates) were stored at 
-20°C for subsequent analysis. 
2.5. Immunoprecipitation [13] 
For immunoprecipitation the conditioned medium (of one 6-cm cell 
culture dish) was first adjusted to 50 mM Tris-HCl, pH 7.5, 150 mM 
NaCI, 2 mM EDTA, 1% Triton X-100 and 2 mM PMSF and then 
medium and cell lysate were incubated for 30 min with 10 ,uI pre- 
immune serum and 30@(3 mg) protein A-Sepharose (Pharmacia). The 
samples were centrifuged briefly and the supernatants (1.5 ml) were 
incubated with antiserum (5 ,uI anti-APP or 20 ~1 anti-2-43) for 90 min 
at room temperature. Following the incubation, 30 ~1 (3 mg) protein 
A-Sepharose was added for an additional 90 min at room temperature. 
The insoluble complexes were washed three times with wash A (IO mM 
Tris-HCI, pH 7.5, I50 mM NaCI, 1% Triton X-100,2 mM EDTA), two 
times with wash B (IO mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.2% 
Triton X-100,2 mM EDTA) and once with wash C (IO mM Tris-HCI 
pH 7.5) before pellets were resuspended in 2 x Laemmli sample buffer. 
After boiling for 5 min at lOO”C, labelled proteins were seperated on 
Tris-tricine gels (16.5% or 8-20%) and fluorographed with 
EN3HANCE (DuPont). 
3. Results 
3.1. Stimulation of PA4 generation from SPAlCT in 
S Y5 Y cells 
To examine the role of protein kinase C in the regula- 
tion of /IA4 production by C-terminal cleavage inde- 
pendent of the processes generating the N-terminus of 
/3A4 (protease 1, y-secretase) or the C-terminus of secre- 
tory APP (APP-secretase, a-secretase), we used SYSY 
cells stably transfected with the C-terminal 100 residues 
of APP, fused to the APP signal sequence (termed 
SPA4CT). Expression of this APP-fragment in SYSY 
cells resulted in a 12 kDa protein associated with the cell 
lysate and a /3A4-like peptide which is immediately se- 
creted into the medium as previously shown [ 111. Peptide 
p3, which is generated from full-length APP by the activ- 
ity of pA4-protease 2 and APP-secretase, is not gener- 
ated from SPA4CT because we showed that APP secre- 
tase does not cleave this C-terminal APP-fragment. 
SYSY cells transfected with SPA4CT were pulse-la- 
belled with [35S]methionine and then chased in the ab- 
sence or presence of compounds which activate PKC 
directly or indirectly by activation of the G-protein-cou- 
pled muscarinic receptor. Treatment of the transfected 
cells with carbachol(1 mM) or PMA (phorbol 12-myris- 
tate 13-acetate) (1 ,uM) stimulates /IA4 generation by 
1.6-and 2-fold, respectively, compared with control cells 
(Fig. 1A and B). The effect of 1 mM carbachol was 
blocked by the muscarinic antagonist atropine (1 PM). 
This carbachol-stimulated /?A4 secretion was medi- 
ated by the muscarinic M, receptor, as shown by the 
effects of selective muscarinic-receptor antagonists 
A 
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Atr 
Co Car Car Car Car PMA 
OA4 
B 
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Fig. 1. Stimulation of /3A4 generation from SPA4CT in SY5Y cells 
SYSY cells stably transfected with CEP/SPA4CT were labelled for 60 
min with [“S]methionine and chased in methionine-enriched medium 
for 3.5 h in the presence or absence of the compounds indicated. The 
conditioned medium was analysed by immunoprecipitation with anti- 
243. Standardisation of the quantity applied in each lane was done by 
measuring the total radioactivity incorporated into protein. Co = con- 
trol; Car = 1 mM carbachol; Atr = preincubation with I yM atropin 
for 15 min; PMA = I ,uM phorbolester. (A) Tris-tricine PAGE (16.5%). 
B: the autoradiography was quantified by densitometric scanning of the 
DA4 band of the autoradiogram (Amersham RAS System). The data 
represent he signal-intensity in percent of the 4 kDa signal of control 
cells. 
(Fig. 2, lane M3). Preincubation of cells with 1 PM 
4-DAMP (M,-receptor antagonist) abolished carbachol- 
induced stimulation of /IA4 secretion, whereas preincu- 
bation with 1 ,uM Telenzepine (M,-receptor antagonist) 
had no effect (Fig. 2, lane Ml). 
3.2. Regulation of APP metabolism by PMA and 
carbachol 
To confirm the role of phosphorylation in the regula- 
tion of /?A4 generation also from full-length APP, the 
effects of the cholinergic agonist carbachol and the phor- 
bol ester PMA were studied in SYSY cells that had been 
transfected with APP695. 
When these transfected cells were incubated with car- 
bachol (1 PM) or PMA (1 ,uM), there was a 1.5-fold or 
2.3-fold increase in the levels of secreted APP respec- 
tively, during a 60 min chase period compared with con- 
trol cells (Fig. 3). Again the effect of 1 mM carbachol was 
blocked by the muscarinic antagonist atropine (1 PM). 
To analyse further the effect of these compounds on 
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Fig. 2. Effect of muscarinic-receptor antagonists on carbachol-induced 
DA4 secretion SYSY cells stably transfected with CEP/SPA4CT were 
labelled for 30 min with [“Slmethionine in the presence or absence of 
1 PM concentrations of the muscarinic-receptor antagonists atropine 
(Atr), telenzepine (Ml) or 4-DAMP (M3) as indicated. Thereafter 
1 mM carbachol (Car) was added and the cells were chased with 
methionine-enriched medium for 3 h. The proteins were analysed by 
16% Tris-tricine-PAGE after immunoprecipitation. Standardisation of 
the quantity applied in each lane was done by measuring the total 
radioactivity incorporated into protein. 
/3A4 generation, the chase time was extended to 3.5 h to 
ensure processing and release of all labelled APP frag- 
ments. Under these conditions, analysis of conditioned 
medium revealed only a 1.2-fold stimulation of APP- 
secretion with carbachol and 1.7-fold with PMA (Fig.4A 
and Fig. 5). This decline of the effect on APP secretion 
in the 3.5 h chase experiment in comparison to the 60 min 
chase time period is due to the short half life time of 
APPsec [ 11. 
In parallel to elevated APP levels in the media, secre- 
tion of a 3-kDa truncated PA4 species (p3), the amount 
of which has been shown to parallel that of APPsec 
released from cells [4,8], was elevated 1.6-fold by car- 
bachol and 3.4-fold by PMA (Figs. 4A and 5). In con- 
trast to the elevated levels of APPsec and p3, the level of 
/IA4 peptide production was unchanged by PKC activa- 
tion. This is surprisingly since an increase of secretory 
APP as a consequence of cleavage within the PA4 do- 
main of APP is expected to reduce the pool of /?A4 
precursors accordingly and thus lower the amount of 
/?A4 molecules released from the cells. 
4. Discussion 
It is now well established that transmembrane APP 
can either undergo secretion as APPsec, be processed 
intoBAClike peptides or degraded in the lysosomal com- 
partment. In this regard, protein kinase C activation by 
APPsec 
co car Atr PMA 
Fig. 3. Release of APPsec upon PKC stimulation SYSY cells stably 
transfected with CEP/695 were labelled for 60 min with [?S]methionine 
and chased in methionine-enriched medium for 60 min in the presence 
or absence of the compounds indicated. The conditioned medium was 
analysed by immunoprecipitation with anti APP. Co = control; Car = 
1 mM carbachol; Atr = preincubation with 1 PM atropine; PMA = 1 
PM phorbolester. Standardisation of the quantity applied in each lane 
was done by measuring the total radioactivity incorporated into pro- 
tein. (Top) Tris-tricine PAGE (S-20%). (Bottom) The autoradiography 
was quantified by densitometric scanning of the APP band of the 
autoradiogram (Amersham RAS System). The data represent the sig- 
nal-intensity in percent of the APP signal of control cells. 
phorbol esters has been shown to stimulate secretion of 
APPsec and to increase the amounts of membrane-re- 
tained C-terminal fragments in PC12 pheochromocy- 
toma cells [ 14,151, as well as in human embryonic kidney 
293 cells [16]. In addition, cells transfected with muscar- 
inic acetylcholine receptor subtypes ml or m3 show in- 
creased secretion of APPsec upon addition of the cholin- 
A 
medium / anti APP 
Co Co Car Car PMAPMA 
APPsec 
B 
medium / anti i3A4 
Co Co Car Car PMA PMA 
OA4 
P3 
Fig. 4. Release of APPsec, p3 and /3A4 upon PKC stimulation. SYSY 
cells transfected with CEP/695 were labelled for 60 min with 
[95S]methionine and chased in methionine-enriched medium for 3.5 h 
in the presence or absence of the compounds indicated. The conditioned 
medium was analysed by immunoprecipitation with anti-APP (A) or 
anti-243 (B) and subsequent Tris-tricine-PAGE (16.5%). Standardisa- 
tion of the quantity applied in each lane was done by measuring the 
total radioactivity incorporated into protein. 
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Fig. 5. Quantification of secreted APP-fragments upon PKC stimulation. APP, p3 and PA4 were quantified by cutting out the precipitated proteins 
from the dried gel (Fig. 4) and measurement of radioactivity in the slices in 5 ml of scintillation fluid. Each column represents the mean of two 
independent experiments. Co = control; Car = 1 mM carbachol; PMA = 1 PM phorbolester. 
ergic agonist carbachol, a process which is blocked by 
the PKC inhibitor staurosporine [ 17,181. Moreover, 
some groups have recently reported that activation of 
PKC, either directly by phorbol esters or indirectly by 
cholinergic agonists, results in a marked inhibition of 
PA4 release [9,19]. 
To examine further the role of protein kinase C in the 
regulation of /3A4 production, we used human neuro- 
blastoma cells stably transfected with both APP and the 
C-terminal 100 residues of APP (SPA4CT). The expres- 
sion strategy allowed membrane insertion and signal 
peptide removal of SPA4CT and thus mimics the natural 
situation of this C-terminal APP fragment. Using these 
stable cell lines permits a more detailed analysis of the 
regulation of the three cleavages involved in /?A4-gener- 
ation and APP secretion. Analysis of cell lysates and 
conditioned medium of the stable cell lines showed that 
both SPA4CT and APP are processed into /?AClike pep- 
tides which are immediately released into the medium 
[ 111. Using the stable SYSY cells expressing SPA4CT we 
have been able to demonstrate for the first time that /?A4 
generation from the C-terminal 100 residues of APP, 
which may be an intermediate in the process of /3A4 
generation [20,21,22], is stimulated by PKC activation. 
In SYSY cells the carbachol-stimulated PA4 secretion 
was mediated by the muscarinic M3 receptor as demon- 
strated by inhibition with the selective M3-receptor an- 
tagonist 4-DAMP. 
By analysing the effect of PKC stimulation on the 
metabolism of full-length APP in SYSY cells we have 
shown that whereas activation of PKC increased the 
generation of APPsec and P3 it did not influence PA4 
generation, an observation in contrast to other results 
obtained with other cell types. These experiments dem- 
onstrate for the first time that in some cellular systems, 
production ofpA is not inhibited by PKC. Because in 
our cell system stimulation of APPsec did not lead to an 
inhibition of /?A4 production, we conclude that in this 
system these two APP processing events, APP secretion 
and /IA4 generation, are not mutually exclusive. Our 
results would suggest he existence of a surplus of full- 
length APP which either gives rise to APPsec, pA4, or 
lysosomal degradation products, depending on the enzy- 
matic activities and regulatory mechanisms present. 
Thus, in SYSY cells the simultaneous activation of APP 
secretase (Cfold), and protease 2 (2-fold), as indicated by 
experiments with the APP- and SPA4CT-transfected 
cells, in total results in two-fold increase in APP secretion 
and no change in the quantity of /3A4 generation. Ac- 
cordingly the consequences of PKC stimulation in differ- 
ent tissue - of cellular systems depends on the kinds of 
enzymatic activities and regulatory mechanisms present. 
While in SYSY cells both /?A4 protease 2 and APP- 
secretase appear to be stimulated by PKC activation, 
other cell types may contain different regulatory mecha- 
nisms for these two proteolytic activities. This is in agree- 
ment with the observation that in some cell types, inhibi- 
tion of /?A4 production can occur without increased 
secretion of APPsec [lo]. 
The conclusion of our results is that different cell types 
seem to exercise different fine-tuning of the APP process- 
ing machinery. Accordingly, results concerning APP reg- 
ulation and PA4 generation in special cell culture sys- 
tems, and therapeutic strategies which are based on these 
results, have to be treated with caution. 
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